Study: Children with vision impairment have reduced quality of life

News
Article

Research from Orbis International analyses the overall wellbeing of children with common childhood vision problems

A child wearing glasses sits in a classroom among her peers who do not have glasses. Image credit: ©Drazen – stock.adobe.com

Orbis noted the impact of vision impairment on quality life and mental health. Image credit: ©Drazen – stock.adobe.com

Orbis International has released results of a study1 that found children with myopia and strabismus often experienced significantly reduced quality of life compared to those without vision impairment.

Published in Ophthalmology, the study also finds that surgical treatment of strabismus improves quality of life among children, underscoring the importance of early detection, treatment and health insurance coverage of strabismus for children.

According to a news release, the research received financial support from Santen, and the study is the first systematic review and meta-analysis of the links between quality of life in children and vision impairment, ocular morbidities and their treatment.

Moreover, Orbis noted in its release quality of life and mental health are increasingly being recognised as important global health concerns. With an estimated 70 million children experiencing vision impairment around the world, understanding the impact of these conditions on mental health is critical.1

The company noted that a child's vision function is assessed by clarity or sharpness of their vision. However, this approach does not measure a child's perception of their own visual impairment and ability to successfully complete daily tasks. For example, chronic eye conditions that may not affect central vision but have other negative impacts, like strabismus, have been shown to cause physical, educational and socioemotional difficulties in their daily lives.

This study is a companion research study2 published last year by Orbis, and also published in Ophthalmology, that found children with myopia and strabismus were diagnosed with higher rates of depression and anxiety than children without vision impairment.

"Our papers in Ophthalmology furnish the strongest evidence yet that impaired vision in children is associated with mental health problems, such as depression and anxiety," Prof Nathan Congdon, director of Research at Orbis International, said in the news release. "This latest study provides an even broader picture of a child's mental health, including quality of life, wellbeing, and self-esteem, meaning we now have a complete story about how a lack of vision care can cause mental health problems for a child."

Reference:

  1. Dongfeng LI, Ving Fai Chan, PhD, Gianni Virgili, PhD, et.al. Impact of Vision Impairment and Ocular Morbidity and Their Treatment on Quality of Life in Children: A Systemic Review.Ophthalmology. Published September 9, 2023. Accessed September 14, 2023. DOI: 10.1016/j.ophtha.2023.09.005.
  2. Dongfeng Li, Ving Fai Chan, PhD, Gianni Virgili, PhD. Impact of Vision Impairment and Ocular Morbidity and Their Treatment on Depression and Anxiety in Children. Ophthalmology. Published October 2022. Accessed September 14, 2023. DOI: 10.1016/j.ophtha.2022.05.020.
Related Videos
Giulia Corradetti, MD, discusses her presentation "Functional Microperimetric Correlates of OCT Structures Features in Intermediate AMD"
Krishna Venkateswaran, PhD, gave an onsite overview of his poster "Predictive Modeling of Clinical Performance of Novel Trifocal IOL"
At this year's ARVO meeting, Paolo Silva, MD, presented data on Protocol AA on behalf of the DRCR Retina Network
Baruch Kuppermann, MD, PhD
At this year's ARVO meeting, Qinqin Zhang, PhD, presented a poster titled "A unified deep learning model for geographic atrophy segmentation: Adaptable to SS-OCT and SD-OCT data with multiple scan patterns."
Ash Abbey, MD, shares 36-month data from the GALE study of pegcetacoplan
Antonio Filipe Macedo, OD, MSc, PhD, speaks about the 2024 ARVO meeting
Dr Srijana Adhikari speaks about her research ahead of the ARVO meeting
David A Berntsen, OD, PhD, FAAO, discusses the BLINK2 study
Professor Shahina Pardhan, BSC, PhD, MBCO, H DHealth Brad, Director of the Vision and Eye Research Institute, School of Medicine, at Anglia Ruskin University in Cambridge, United Kingdom.
© 2024 MJH Life Sciences

All rights reserved.